60 Seconds with Dr Marwa Ali
August 6, 2021 – 87, 135 Brompton Rd, London SW1X 7XL, UK
60 Seconds with Dr. Marwa Ali from the Harrods Wellness Clinic and Lumenis Ambassador for the Stellar M22
What does the Stellar M22TM treat?
It can treat more than 30 skin conditions as well as hair removal, and is especially know for it’s efficacy in treating different types of pigmentation, such as sun spots, melasma, and all kinds of dyschromia. It has four light/laser modalities, and combining them in the same session helps get optimal results. The Photofractional treatment, for example, combines IPL and ResurFXTM – a non-ablative fractional laser, and is ideal for managing tone and texture in just one setting. The results that we have seen from the Stellar M22 are incredible due to its combined different modalities where a treatment plan can be created that is bespoke to each patient’s needs, skin type and lifestyle.
Can you tell us a little more about the science behind the Stellar M22 and how it gets results?
In four innovative technologies, the Stellar M22 offers a versatile IPL applicator to treat more than 20 Skin conditions, including acne, rosacea, pigmented lesions and vascular lesions, reduction of age spots and hair removal; a Multi-SpotNd:YAG to deliver precise treatment of vascular leg vein lesions on all skin types; a Q-Switched Nd:YAG for the treatment of pigmented lesions and dark tattoo removal; and a ResurFXTM, a fractional laser with non-ablative scanner for a high-end treatment of stretch marks, scars and skin rejuvenation.
Any last thoughts on the new platform?
We’re very proud to offer one of the newest and most innovative treatments available on the market and are therefore thrilled to be adding the Lumenis Stellar M22TM to our Harrods Wellness Clinic menu. I’m very excited by the capabilities of this system as some of the conditions it combats have previously been deemed untreatable. I can’t wait to introduce my patients to the Stellar M22 by Lumenis and to use it to its full potential.
Find out more about the Stellar M22 from Lumenis.
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology, and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For 50 years, Lumenis’ ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods. visit: www.lumenis.com
Information provided in this press release may contain statements relating to current expectations, estimates, forecasts and projections about future events that are forward-looking statements. These forward-looking statements may include but are not limited to the Company’s plans, objectives and expectations for future operations, including its projected results of operations. Forward-looking statements are often characterized by the use of forward-looking terminology such as “may,” “will,” “expect,” “anticipate,” “estimate,” “continue,” “believe,” “should,” “intend,” “plan,” “project” or other similar words, but are not the only way these statements are identified. These forward-looking statements are based upon our management’s current estimates and projections of future results or trends. Actual results may differ materially from those projected as a result of certain risks and uncertainties. These forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether a result of new information, future events or otherwise.
For further information, contact 5W Public Relations at Lumenis@5wpr.com.